AIKO Reinforces Long-Term Commitment to Australia at SNEC 2026 with Multiple Distribution MOUs, Top Brand PV Award, and New Market Milestones
SHANGHAI, June 10, 2026 /PRNewswire/ -- AIKO Energy has announced a series of developments at SNEC 2026 that strengthen its position in the Australian solar market, including multiple distribution MOUs with local partners, recognition as Top Brand...
Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
NANJING, China, June 5, 2026 /PRNewswire/ -- NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the combination of an NTRK gene containing a kinase...
Update on the Proposed Dual Listing on the Nasdaq Stock Market
SINGAPORE, June 3, 2026 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") wishes to update shareholders of the Company ("Shareholders") that it remains on schedule for its...
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test
SINGAPORE, May 28, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted...
SK chemicals' Seven Plastic Materials Confirmed Compatible with European Recycling Processes
- "Full compatibility" verified with PET bottle recycling streams, proving recyclability from the material design stage SK chemicals' plastic materials have secured verification of their compatibility as feedstock for recycling processes in Europe....
World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
CHONGQING, China, April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project...
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone
GOTHENBURG, Sweden, April 21, 2026 /PRNewswire/ -- "We succeeded in surpassing last year's record-breaking first quarter with organic growth in both net sales and order intake," says Mattias Perjos, President & CEO at Getinge. The medtech...
Innovations Centered on 'A Better Life for Customers' Win at LG Awards
SEOUL, South Korea, April 20, 2026 /PRNewswire/ -- Innovations focused on a better life for customers were recognized for their outstanding impact at the LG Awards. Four projects that generated tangible results, such as increased sales and orders,...
SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
SHANGHAI, April 15, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST001), an α-synuclein (α-syn) targeted PET tracer...
HiTHIUM's kAh-Level 6.25MWh BESS Receives International Certification Following Large-Scale Fire Test
BEIJING, April 3, 2026 /PRNewswire/ -- HiTHIUM showcased its full-scenario energy storage solutions at ESIE 2026, held in Beijing from April 1-3. The company highlighted its ∞Cell 1175Ah long-duration energy storage (LDES) battery and BESS, along...